Marshall Wace
ANGO icon

Marshall Wace’s AngioDynamics ANGO Stock Holding History

Marshall Wace’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47M Sell
420,378
-65,126
-13% -$741K ﹤0.01% 1327
2026
Q1 		$5.52M Buy
485,504
+200,816
+71% +$2.18M 0.01% 1257
2025
Q4 		$3.66M Sell
284,688
-53,459
-16% -$660K ﹤0.01% 1294
2025
Q3 		$3.78M Sell
338,147
-67,971
-17% -$656K ﹤0.01% 1310
2025
Q2 		$4.03M Sell
406,118
-21,956
-5% -$215K ﹤0.01% 1254
2025
Q1 		$4.02M Sell
428,074
-48,750
-10% -$512K 0.01% 1170
2024
Q4 		$4.37M Buy
476,824
+443,598
+1,335% +$3.26M 0.01% 1117
2024
Q3 		$258K Sell
33,226
-34,231
-51% -$247K ﹤0.01% 2207
2024
Q2 		$408K Sell
67,457
-218,500
-76% -$1.35M ﹤0.01% 2038
2024
Q1 		$1.68M Buy
285,957
+267,357
+1,437% +$1.59M ﹤0.01% 1441
2023
Q4 		$146K Sell
18,600
-117,761
-86% -$817K ﹤0.01% 2018
2023
Q3 		$997K Buy
+136,361
New +$1.13M ﹤0.01% 1504
2023
Q2 		– Sell
-28,694
Closed -$297K – 2434
2023
Q1 		$297K Sell
28,694
-43,271
-60% -$554K ﹤0.01% 2304
2022
Q4 		$991K Buy
+71,965
New +$1M ﹤0.01% 2097
2020
Q2 		– Sell
-33,972
Closed -$354K – 1518
2020
Q1 		$354K Sell
33,972
-270,114
-89% -$3.39M ﹤0.01% 1054
2019
Q4 		$4.87M Buy
304,086
+184,127
+153% +$2.81M 0.03% 543
2019
Q3 		$2.21M Buy
119,959
+104,258
+664% +$2.04M 0.02% 737
2019
Q2 		$310K Buy
+15,701
New +$320K ﹤0.01% 1177

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace's ANGO Position: Q2 2026 in Review

Marshall Wace reduced its AngioDynamics (ANGO) stake by 13% in Q2 2026, selling an estimated $741K and leaving 420,378 shares worth $5.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Marshall Wace first reported a position in ANGO in Q2 2019 and has held it in 18 quarters since. The position peaked at $5.52M in Q1 2026. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Marshall Wace held 420,378 shares of AngioDynamics worth $5.47M as of Q2 2026.
  • Marshall Wace sold 65,126 AngioDynamics shares in Q2 2026, an estimated $741K.
  • AngioDynamics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1327 holding.
  • Marshall Wace first reported a position in AngioDynamics in Q2 2019 and has held it in 18 quarters since.
  • Marshall Wace's AngioDynamics position peaked at $5.52M in Q1 2026.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.